Biovie's three largest insider shareholders as of September 09, 2026 are Penelope Markham (Evp Liver Cirrhosis Rd, 47.84K shares), Joanne Wendy Kim (Chief Financial Officer, 44.15K shares), Robert J Hariri (Director, 42.25K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Robert J Hariri | Director | 76,494 | 0 | 76,494 | 23.7% | 05 Dec, 2023 |
| 2 | Penelope Markham | Evp Liver Cirrhosis Rd | 47,841 | 0 | 47,841 | 14.8% | 22 Feb, 2023 |
| 3 | Joanne Wendy Kim | Chief Financial Officer | 44,589 | 0 | 44,589 | 13.8% | 28 Aug, 2026 |
| 4 | Joseph M Palumbo | Chief Medical Officer | 43,184 | 0 | 43,184 | 13.4% | 28 Aug, 2026 |
| 5 | Christopher Reading | Evp Neuroscience Rd | 37,148 | 0 | 37,148 | 11.5% | 22 Feb, 2023 |
| 6 | Sigmund Rogich | Director | 36,926 | 0 | 36,926 | 11.5% | 07 Jan, 2025 |
| 7 | Terren S Peizer | Director, TenPercentOwner | 0 | 18,533 | 18,533 | 5.8% | 16 Aug, 2022 |
| 8 | Cuong V Do | President Ceo | 16,117 | 533 | 16,650 | 5.2% | 28 Aug, 2026 |
| 9 | Amy Suzon Chappell | Director | 727 | 0 | 727 | 0.2% | 28 Aug, 2026 |
| 10 | Steve Gorlin | Director | 104 | 0 | 104 | 0.0% | 05 Dec, 2023 |
| 11 | Jonathan M Adams | Evp Liver Cirrhosis Programs | 39 | 0 | 39 | 0.0% | 15 Feb, 2022 |
| 12 | Richard J Berman | Director | 31 | 0 | 31 | 0.0% | 07 Jan, 2025 |
| 13 | Clarence N. Ahlem | Evp Neuroscience Product Dev. | 30 | 0 | 30 | 0.0% | 21 Feb, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 28 Aug, 2026 | Joseph M Palumbo | Chief Medical Officer | Acquired P | 4,843 | $2.16 | $10.46K | 6,036 | Direct |
| 28 Aug, 2026 | Amy Suzon Chappell | Director | Acquired P | 727 | $2.16 | $1.57K | 727 | Direct |
| 28 Aug, 2026 | Joanne Wendy Kim | Chief Financial Officer | Acquired P | 2,500 | $2.18 | $5.45K | 3,441 | Direct |
| 27 Aug, 2026 | Cuong V Do | President Ceo | Acquired P | 15,210 | $2.08 | $31.64K | 16,117 | Direct |
| 05 Jan, 2026 | Joseph M Palumbo | Chief Medical Officer | Acquired A | 132,000 | $0.00 | $0 | 132,000 | Direct |
| 05 Jan, 2026 | Sigmund Rogich | Director | Acquired A | 70,000 | $0.00 | $0 | 70,000 | Direct |
| 05 Jan, 2026 | James Paul Lang | Director | Acquired A | 90,000 | $0.00 | $0 | 90,000 | Direct |
| 05 Jan, 2026 | Joanne Wendy Kim | Chief Financial Officer | Acquired A | 110,100 | $0.00 | $0 | 110,100 | Direct |
| 05 Jan, 2026 | Michael Edward Sherman | Director | Acquired A | 80,000 | $0.00 | $0 | 80,000 | Direct |
| 05 Jan, 2026 | Sigmund Rogich | Director | Acquired A | 70,000 | $0.00 | $0 | 70,000 | Direct |
| 05 Jan, 2026 | Joanne Wendy Kim | Chief Financial Officer | Acquired A | 110,100 | $0.00 | $0 | 110,100 | Direct |
| 05 Jan, 2026 | Joanne Wendy Kim | Chief Financial Officer | Acquired A | 110,100 | $0.00 | $0 | 110,100 | Direct |
| 05 Jan, 2026 | Sigmund Rogich | Director | Acquired A | 70,000 | $0.00 | $0 | 70,000 | Direct |
| 05 Jan, 2026 | Joseph M Palumbo | Chief Medical Officer | Acquired A | 132,000 | $0.00 | $0 | 132,000 | Direct |
| 05 Jan, 2026 | Joseph M Palumbo | Chief Medical Officer | Acquired A | 132,000 | $0.00 | $0 | 132,000 | Direct |
| 05 Jan, 2026 | Michael Edward Sherman | Director | Acquired A | 80,000 | $0.00 | $0 | 80,000 | Direct |
| 05 Jan, 2026 | Sigmund Rogich | Director | Acquired A | 70,000 | $0.00 | $0 | 70,000 | Direct |
| 05 Jan, 2026 | Michael Edward Sherman | Director | Acquired A | 80,000 | $0.00 | $0 | 80,000 | Direct |
| 05 Jan, 2026 | Joanne Wendy Kim | Chief Financial Officer | Acquired A | 110,100 | $0.00 | $0 | 110,100 | Direct |
| 05 Jan, 2026 | Cuong V Do | President Ceo | Acquired A | 665,300 | $0.00 | $0 | 665,300 | Indirect |